Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Whitehawk Therapeutics Inc (WHWK)

61 + Investors. Track Smart Money conviction in WHWK. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +14
Streak
3Q ▲
Buyers last Q
69%

Smart Money Signals — WHWK

Based on 61 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added WHWK than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
61 funds currently hold this stock — 92% of the 3.0-year high of 66 funds (reached 2023 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q
+12 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 69% buying

36 buying16 selling
Last quarter: 36 funds were net buyers (21 opened a brand new position + 15 added to an existing one). Only 16 were sellers (9 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+9 vs last Q)

new funds entering per quarter
Funds opening a new WHWK position: 2 → 4 → 12 → 21. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

46% of holders stayed for 2+ years

■ 46% conviction (2yr+) ■ 26% medium ■ 28% new
28 out of 61 hedge funds have held WHWK for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +4%, value -17%

Value
-17%
Shares
+4%
Last quarter: funds added +4% more shares while total portfolio value only changed -17%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

9 → 2 → 4 → 12 → 21 new funds/Q
New funds entering each quarter: 2 → 4 → 12 → 21. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 58% veterans vs 29% newcomers

■ 58% veterans ■ 13% 1-2yr ■ 29% new
Entry-cohort mix of 62 holders: 36 (58%) are 2+ year veterans, 8 entered 1–2 years ago, and 18 (29%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 6% AUM from top-100

6% from top-100 AUM funds
18 of 61 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — WHWK

In 2026 Q1, 36 hedge funds were net buyers of WHWK (21 opened a new position, 15 added to an existing one), while 16 reduced or exited (9 trimmed, 7 sold completely) — a 69% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +14 funds (more new holders than closures). Total institutional holders: 61.

Hedge Fund Ownership: WHWK

How many hedge funds hold WHWK — quarterly history vs. share price
Quarterly hedge fund ownership of WHWK vs. share price

Market Analysis: WHWK

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: WHWK

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Whitehawk Therapeutics Inc (WHWK) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much WHWK has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 46d ago
WHWK
-2.6%
XLV
+5.5%

WHWK outperformed XLV by -8.1% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 1d ago
WHWK
+0.0%
XLV
+0.0%

Since the filing became public, WHWK outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 2 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
2.1
/ 10
conviction
Hedge Fund Positioning: WHWK
2026 Q2 Stats Unlock in 4 days 61 + Investors

Track Smart Money conviction in WHWK. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 61 47 29.79%
13F Shares 34M 33M 3.99%
Total Value $119M $144M -16.95%
New Positions 21 12 +9
Increased Positions 15 10 +5
Closed Positions 7 4 +3
Reduced Positions 8 6 +2
Total Calls 0 0 -
Total Puts 1 0 100%
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: WHWK

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

61 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in WHWK. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 WHWK holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Yu Fan 20.63% 4,861,314 $22.3M
2 Acuta Capital Partners, LLC 14.96% 4,685,912 $21.5M
3 KVP Capital Advisors, LP 7.28% 2,165,997 $9.9M
4 Ally Bridge Group (NY) LLC 3.31% 817,939 $3.7M
5 Acorn Capital Advisors, LLC 1.42% 1,139,363 $5.2M
6 Verdad Advisers, LP 1.32% 301,483 $1.4M
7 QVT Financial LP 1.24% 4,615,709 $21.1M
8 Stempoint Capital LP 0.81% 1,021,037 $4.7M
9 Montanova Capital, LLC 0.36% 4,300,000 $19.7M
10 Orbimed Advisors LLC 0.33% 3,934,296 $18.0M
11 ADAR1 Capital Management, LLC 0.28% 1,341,394 $6.1M
12 Siren, L.L.C. 0.22% 2,337,102 $10.7M
13 Avoro Capital Advisors LLC 0.12% 2,849,402 $13.1M
14 Eversept Partners, LP 0.07% 303,306 $1.4M
15 Scientech Research LLC 0.04% 10,838 $50K
16 Bridgeway Capital Management, LLC 0.01% 165,284 $757K
17 Woodline Partners LP 0.01% 436,614 $2.0M
18 Two Sigma Securities, LLC 0.00% 10,033 $46K
19 Renaissance Technologies LLC 0.00% 413,822 $1.9M
20 Y-Intercept (Hong Kong) Ltd 0.00% 24,363 $112K
21 Balyasny Asset Management L.P. 0.00% 288,117 $1.3M
22 XTX Topco Ltd 0.00% 18,522 $85K
23 Two Sigma Investments, LP 0.00% 296,612 $1.4M
24 Evergreen Capital Management LLC 0.00% 11,000 $50K
25 Millennium Management LLC 0.00% 380,406 $1.7M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Whitehawk Therapeutics Inc (WHWK)

What does the Smart Money Trend signal show for WHWK?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added WHWK than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for WHWK?

More buyers than sellers — 69% buying: Last quarter: 36 funds were net buyers (21 opened a brand new position + 15 added to an existing one). Only 16 were sellers (9 trimmed + 7 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for WHWK holders?

Smaller funds dominant — 6% AUM from top-100: 18 of 61 holders rank in the top 100 by AUM, but together hold only 6% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held WHWK?

46% of holders stayed for 2+ years: 28 out of 61 hedge funds have held WHWK for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Whitehawk Therapeutics Inc (WHWK) following the 2026 Q2 hedge fund 13F filings?

As of today, WHWK has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), WHWK has gained -2.6% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →